Related Experiment Video
Updated: Oct 9, 2025

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Oropharyngeal colostrum immunotherapy and nutrition in preterm newborns: meta-analysis
Michelle de Santana Xavier Ramos1,2, Camilla da Cruz Martins1, Elivan Silva Souza3
1Universidade Estadual de Feira de Santana. Departamento de Saúde. Feira de Santana, BA, Brasil.
Insights
Oropharyngeal colostrum immunotherapy significantly reduced the time for very low birth weight preterm newborns to achieve full enteral nutrition. This intervention offers a promising approach for improving feeding outcomes in vulnerable infants.
Area of Science:
- Neonatalogy
- Immunology
- Gastroenterology
Background:
- Very low birth weight preterm newborns (VLBW-PTNB) often face challenges in achieving full enteral nutrition.
- Early initiation of nutrition is crucial for growth and development in preterm infants.
- Oropharyngeal colostrum administration is being explored as a method to enhance feeding tolerance.
Purpose of the Study:
- To investigate the efficacy of oropharyngeal colostrum immunotherapy in shortening the time to full enteral nutrition for VLBW-PTNB.
- To compare feeding outcomes between VLBW-PTNB receiving oropharyngeal colostrum immunotherapy and those receiving placebo or routine care.
Main Methods:
- A systematic literature search was conducted across multiple databases and gray literature.
- Randomized clinical trials were included without date or language restrictions.
- A random-effects meta-analysis was performed on data from 764 VLBW-PTNB across five selected studies.
Main Results:
- Meta-analysis of five studies involving 708 VLBW-PTNB indicated a mean difference of -4.26 days to achieve full enteral nutrition.
- Three studies reported shorter feeding times in the immunotherapy group.
- High heterogeneity (I2 = 83.1%) was observed among the studies.
Conclusions:
- Oropharyngeal colostrum immunotherapy demonstrates potential in reducing the time for VLBW-PTNB to reach full enteral nutrition.
- This therapeutic approach may offer benefits over placebo or standard care in improving feeding progression for preterm infants.
- Further research may be warranted to explore optimal protocols and long-term outcomes.
Objective:
To investigated the effect of oropharyngeal colostrum immunotherapy in reducing the time required for very low birth weight preterm newborns (VLBW-PTNB: < 1,500g and < 37 weeks) to achieve full enteral nutrition.
Methods:
Literature search was conducted using four databases, including gray literature, with additional manual search of the references of selected articles. Eligibility criteria consisted of randomized clinical trials, without restriction regarding the date or language of the publication. Two independent reviewers performed the article selection and data extraction. The random-effects meta-analysis used a non-standard technique to assess the mean difference in days to achieve full enteral nutrition, carried out by the Stata 15 statistic program.
Results:
The systematic review comprised 10 studies, and five were selected for meta-analysis, with a population of 764 VLBW-PTNB and gestational age of birth between 25 and 32 weeks. The studies were conducted between 2011 and 2018 in North America, Asia and Africa, with only one conducted in South America. Altogether, they reported the number of days it took 708 VLBW-PTNB to achieve full enteral nutrition, with newborns treated with immunotherapy showing a shorter time in only three studies. Meta-analysis showed a mean difference of -4.26 days, (95% CI -7.44; -1.08d), with high heterogeneity (I2 = 83.1%).
Conclusion:
The use of oropharyngeal colostrum immunotherapy can reduce the time for VLBW-PTNB to achieve full nutrition when compared to those who used a placebo or received routine care.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Drug Dosing: Infants and Children

